Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisGabriela Mladonická Pavlasová, Marek Mráz, Marek Borský et al.|Blood|2016Cited by 108
<i>miR-29</i> modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Marek Mráz, Gabriela Mladonická Pavlasová et al.|Blood|2021Cited by 63
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Peter Valent, Massimiliano Bonifacio et al.|Leukemia|2021Cited by 55
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E. Kennedy, Hanneke Oude Elberink, Cecelia Perkins et al.|Blood Advances|2022Cited by 39
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 <sup>+</sup> Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic LeukemiaJean‐Baptiste Robin, Éolia Brissot, Mathilde Hunault et al.|Journal of Clinical Oncology|2024Cited by 33